Author Correction: Targeting cardiac fibrosis with engineered T cells

Haig Aghajanian^{1

2

3}, Toru Kimura⁴, Joel G Rurik^{1

2

3}, Aidan S Hancock^{1

2

3}, Michael S Leibowitz^{5

6}, Li Li^{1

2

3}, John Scholler⁷, James Monslow⁸, Albert Lo⁸, Wei Han⁹, Tao Wang², Kenneth Bedi^{2

4}, Michael P Morley^{2

4}, Ricardo A Linares Saldana^{1

2

3}, Nikhita A Bolar^{1

2

3}, Kendra McDaid², Charles-Antoine Assenmacher¹⁰, Cheryl L Smith^{1

2

3}, Dagmar Wirth¹¹, Carl H June⁷, Kenneth B Margulies^{2

4}, Rajan Jain^{1

2

3

4}, Ellen Puré⁸, Steven M Albelda⁴, Jonathan A Epstein^{12

13

14

15}

Affiliations

¹ Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
² Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁵ Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁶ Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
⁷ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁸ Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁹ Echocardiography Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
¹⁰ Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
¹¹ Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research, Braunschweig, Germany.
¹² Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.
¹³ Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.
¹⁴ Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.
¹⁵ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.

PMID: 31723271
DOI: 10.1038/s41586-019-1761-7

Published Erratum

Author Correction: Targeting cardiac fibrosis with engineered T cells

Haig Aghajanian et al. Nature. 2019 Dec.

. 2019 Dec;576(7785):E2.

doi: 10.1038/s41586-019-1761-7.

Authors

Affiliations

¹ Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
² Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
³ Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁵ Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁶ Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
⁷ Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁸ Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁹ Echocardiography Laboratory, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
¹⁰ Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
¹¹ Model Systems for Infection and Immunity, Helmholtz Centre for Infection Research, Braunschweig, Germany.
¹² Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.
¹³ Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.
¹⁴ Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.
¹⁵ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. epsteinj@upenn.edu.

PMID: 31723271
DOI: 10.1038/s41586-019-1761-7

Abstract

An Amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

Targeting cardiac fibrosis with engineered T cells.
Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, Scholler J, Monslow J, Lo A, Han W, Wang T, Bedi K, Morley MP, Linares Saldana RA, Bolar NA, McDaid K, Assenmacher CA, Smith CL, Wirth D, June CH, Margulies KB, Jain R, Puré E, Albelda SM, Epstein JA. Aghajanian H, et al. Nature. 2019 Sep;573(7774):430-433. doi: 10.1038/s41586-019-1546-z. Epub 2019 Sep 11. Nature. 2019. PMID: 31511695 Free PMC article.

Publication types

Actions

Grants and funding

S10 OD023465/OD/NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Targeting cardiac fibrosis with engineered T cells

Affiliations

Author Correction: Targeting cardiac fibrosis with engineered T cells

Authors

Affiliations

Abstract

Erratum for

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources